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OBJECTIVES The objective of this study was to examine the relationship between quantitative volumetric
and cross-sectional measures of residual atheroma burden and neointimal growth after
coronary stenting.
BACKGROUND Previous intravascular ultrasound (IVUS) studies have demonstrated a correlation between
residual atheroma burden and neointimal growth after coronary stenting. However, post-
mortem studies contradict this finding.
METHODS The study population included 34 patients who underwent IVUS six to eight months after
stent placement, including 26 patients who underwent IVUS immediately after stent
placement and at six to eight months follow-up. Using manual planimetry, the lumen
cross-sectional area (LA), stent cross-sectional area (SA) and external elastic membrane
cross-sectional area (EEM) were measured at 1-mm intervals after the procedure and at
follow-up. Percent neointimal area (NA) and atheroma area (AA) were calculated as: percent
neointimal area  ([SA  LA]/SA)  100; percent AA  ([EEM  SA]/EEM)  100 in
the entire cross section and in individual quadrants. Postinterventional atheroma volume and
neointimal volume at follow-up were calculated using Simpsons’s rule.
RESULTS In pooled analyses using all cross sections and cross-sectional quadrants, there was a weak
correlation between percent AA and NA (r  0.11 and 0.12, respectively). Analysis in
individual patients demonstrated no significant relationship between total or quadrant
measurements of percent AA and NA (p  0.47 and 0.4, respectively). No relationship
between atheroma volume postintervention and neointimal volume at follow-up was observed
(r  0.1, p  0.62).
CONCLUSIONS This study failed to demonstrate a clinically significant relationship between quantitative
volumetric and cross-sectional measures of residual atheroma burden and subsequent
neointimal growth. (J Am Coll Cardiol 2002;40:1573–8) © 2002 by the American College
of Cardiology Foundation
Coronary stents are used in approximately 80% of percuta-
neous coronary intervention procedures in the U.S. (1). By
preventing negative remodeling (2,3), stents reduce the
overall rate of restenosis compared with angioplasty alone
(4,5). However, stent placement is associated with an
increased amount of neointimal tissue formation compared
with balloon angioplasty and atherectomy (6,7), resulting in
in-stent restenosis rates of 15% to 50% depending on a
variety of patient-, lesion- and procedure-related factors (7).
A direct correlation between various measures of ather-
oma burden and the degree of neointimal growth after stent
placement has been reported in nonrandomized intravascu-
lar ultrasound (IVUS) studies (8–12). Methods used to
describe this relationship include volumetric analyses relat-
ing atheroma volume immediately after intervention to
neointimal volume at the time of follow-up (usually six
months) (11). Other two-dimensional IVUS studies have
examined the axial and circumferential relationship between
atheroma and neointima (8–11). In contrast, a large post-
mortem histologic analysis of in-stent restenosis obtained
from 55 stents in 32 human patients demonstrated that
neointimal thickness was greatest at sites of medial damage
independent of whether stent struts were in contact with
atheroma versus intact media (13).
The IVUS substudy of the Atherectomy before MULTI-
LINK Improves Lumen Gain and Clinical Outcomes
(AMIGO) trial offered the opportunity to re-examine the
relationship between the quantitative measures of atheroma
burden and neointimal growth. An accurate determination
of these relationships has important implications for the
understanding of the pathogenesis of neointimal growth
and also on the clinical practice of lesion “debulking” (i.e.,
atherectomy) before stenting as a strategy to reduce in-stent
restenosis.
METHODS
Patient population. The study population consisted of
patients from the IVUS substudy of the AMIGO trial. The
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AMIGO trial was a randomized trial that compared the late
angiographic and clinical outcomes of patients undergoing
stent placement alone, or stent placement after debulking
using directional atherectomy of a single de novo or first-
time restenotic lesion in native coronary arteries. In a subset
of these patients, IVUS examinations were performed im-
mediately after intervention and at six to eight months
follow-up.
Image acquisition. Before the IVUS study, patients re-
ceived 100–200 g of intracoronary nitroglycerin. Com-
mercially available catheter systems with automated (motor-
ized) pullback were used. These included the 3.5F
Endosonics VISIONS Five-64 F/X catheter (20 MHz), the
2.9F and 3.2F BSC Ultracross imaging catheters (30 MHz)
or the 2.6Fr Discovery imaging catheter (40 MHz). The
same type of catheter and equipment were used at baseline
and follow-up examinations in each patient. Motorized
pullbacks were performed at 0.5 mm/s and were recorded on
super-VHS videotape for offline analysis at the Cleveland
Clinic Foundation IVUS core laboratory.
Image analysis. The entire postintervention and follow-up
pullbacks were digitized. Cross sections at 1-mm intervals
were selected for analysis and single-slice two-dimensional
cross sections were selected at 1-mm intervals for quantita-
tive analysis. Manual planimetry at each cross section was
performed and measurements were obtained at each cross-
section (Fig. 1), including lumen area (LA), stent area (SA)
and external elastic membrane area (EEM). In cross sec-
tions acquired immediately postintervention, LA and SA
were identical. Atheroma area (AA) and neointimal area
(NA) were calculated as follows: AA  EEM  SA;
NA  SA  LA.
Data Analysis
Cross-sectional analysis. AXIAL RELATIONSHIP BETWEEN
ATHEROMA AND NEOINTIMA. The axial relationship be-
tween atheroma and neointima was determined by examin-
ing the relationship between a measure of total atheroma
and total neointima in the same cross section from
follow-up IVUS images. Using the data from all cross
sections at six to eight months follow-up with complete
measurements of LA, SA, and EEM, we calculated
percent NA ([SA  LA)/SA]  100) and percent AA
([EEM  SA)/EEM]  100) in each cross section.
Abbreviations and Acronyms
AA  atheroma area
AMIGO  Atherectomy Before MULTI-LINK
Improves Lumen Gain and Clinical
Outcomes trial
EEM  external elastic membrane cross-sectional
area
IVUS  intravascular ultrasound
LA  lumen cross-sectional area
NA  neointimal area
SA  stent cross-sectional area
Figure 1. Intravascular ultrasound images obtained postintervention and at follow-up demonstrating the measurements performed by manual planimetry
at each time point. EEM  external elastic membrane area.
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CIRCUMFERENTIAL RELATIONSHIP BETWEEN ATHEROMA
AND NEOINTIMA. The circumferential relationship between
atheroma and neointima was determined by examining the
relationship between a quantitative measure of atheroma
and neointima distribution in the same cross section from
follow-up IVUS images. Using the IVUS pullbacks ob-
tained at six to eight months follow-up, five representative
cross sections along the length of the stent were identified in
each patient using a set of predefined rules: for stents 20
mm in length, cross sections at 3 and 6 mm from the stent
edges and at the center of the stent were analyzed; for stents
20 mm in length, cross sections at 4 and 8 mm from the
stent edges, and at the center of the stent were analyzed.
Where nonmeasurable borders (because of calcification or
artifacts) existed at these predefined sites, the nearest
proximal cross section was included in the analysis.
Each cross section was divided into four quadrants such
that one of the quadrants contained the maximal AA. This
was achieved using two intersecting perpendicular lines
placed over the image with the intersection point of the lines
being placed at the center of the lumen (Fig. 2). Within
each quadrant, the EEM, AA, SA, and NA were deter-
mined by planimetry. Percent AA (AA/EEM) and percent
NA (NA/SA) for each quadrant was calculated as previously
described. Where there was a uniform distribution of
atheroma in all four quadrants, perpendicular lines extend-
ing from 0° to 180° and 90° to 270° were constructed and the
relevant measurements made in each quadrant.
Volumetric analysis. Volumetric analysis relating ather-
oma volume postintervention to neointimal volume at
follow-up was performed in those patients with IVUS
pullback data immediately after intervention and at
follow-up and in which complete planimetry of the appro-
priate borders in 70% of cross sections in a given pullback
was possible. Volumes were calculated using Simpson’s rule:
Atheroma volume post-intervention:
 
i1
n
EEM LAi n  stent length
n  number of frames
Neointimal volume at follow-up:
 
i1
n
SA LAi n  stent length n  number of frames
Percent atheroma and neointimal volumes were derived as
follows: percent atheroma volume  atheroma volume/
vessel volume; percent neointimal volume  neointimal
volume/stent volume.
Reproducibility. To assess the reproducibility of planime-
tered measurements, 20 cross sections from 20 different
patients were randomly selected. Using manual planimetry,
two independent observers measured total EEM, SA and
LA in each cross section. To assess the reproducibility of the
method we used to quantify the circumferential relationship
between atheroma and neointima, two independent observ-
ers performed manual planimetry of the EEM, SA, NA and
AA in the quadrant of these cross sections that were deemed
to have the maximal AA.
Statistical analysis. Continuous variables are reported as
means with standard deviations and categorical variables as
frequencies with percentages. Simple linear regression was
used to relate the percent AA (or volume) to percent NA (or
volume). A one-sided t test was used to assess whether the
mean linear regression slope (i.e.,  parameter estimate)
across all patients differed from zero.
RESULTS
The entire cohort of 34 patients was included in the
cross-sectional analysis. Of these, 26 patients had IVUS
pullbacks in which70% of the cross sections had complete
Figure 2. Cross-sectional intravascular ultrasound image obtained at six months follow-up illustrating the method used to examine the circumferential
relationship of atheroma and neointima. The vessel is divided into quadrants with the first quadrant containing the maximum of atheroma. Lumen, external
elastic membrane cross-sectional area (EEM), atheroma and neointimal areas are planimetered in each quadrant as illustrated.
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planimetry of EEM, SA, and LA borders and were included
in the volumetric analysis. The clinical and procedural
characteristics of the entire cohort are shown in Table 1.
The MULTI-LINK ACS was the only stent used in the
study with an average stent length of 23 mm. All but two
patients had a single stent inserted. Follow-up IVUS exam-
ination was performed as part of the study protocol in 31
patients and was performed for a clinical indication in the
remaining three patients. The angiographic restenosis rate
(i.e., angiographic stenosis 50%) for the 34 patient cohort
was 12.5%.
Cross-sectional analysis. AXIAL RELATIONSHIP BETWEEN
ATHEROMA AND NEOINTIMA. A total of 757 cross sections
at 1-mm intervals were acquired from IVUS pullbacks of
the stented region in 34 patients. Thirty-three cross sections
(4.4%) were excluded because of calcification, 41 (5.4%)
because of branch vessels, and 51(6.7%) because of shadow-
ing from stent struts. The remaining 626 (83%) cross-
sections with measurable EEM, LA and SA borders were
included in the analysis.
In the pooled analysis of these 626 intrastent cross
sections, the mean percent total AA and NA were 51.3 
9.3% and 28.1  20.2%, respectively. A weak positive corre-
lation between percent residual AA and percent NA was found
(r  0.11; Fig. 3). In 297 intrastent cross sections from the 15
patients who had percent NA 50% in any cross section, a
greater but still weakly positive correlation between percent
AA and NA was present (r  0.24, r2  0.06).
When linear regression analyses were performed for each
individual patient, a statistically significant positive correla-
tion between percent NA and AA was found in eight
patients, a significant negative correlation was seen in
another four patients, and no statistically significant rela-
tionship was seen in the remainder. The mean of all
regression line slopes was 0.129  1.033, which was not
statistically different from zero (one-sided p value 0.47).
CIRCUMFERENTIAL RELATIONSHIP BETWEEN DISTRIBU-
TION OF ATHEROMA AND NEOINTIMA IN EACH CROSS SEC-
TION. In the pooled analysis of 556 quadrants from 139
representative cross sections identified in the 34 patients
included in this analysis, a weak positive correlation was
observed between percent atheroma and neointimal areas in
each quadrant (r  0.12). A statistically significant positive
correlation was found in four patients and a statistically
significant negative correlation was found in four patients.
No correlation was found in quadrant measurements from
the remaining 26 patients. The mean of all slopes was 0.074
 0.495 (one-sided t test, p  0.4).
Volumetric analysis. No statistically significant relation-
ship was observed between atheroma volume after interven-
tion and neointimal volume at follow-up in 26 patients with
an IVUS pullback performed at both time points (r  0.1,
p  0.62) (Fig. 4).
Reproducibility. The intraclass correlation coefficients for
measurements of total EEM, SA, and LA were 0.93, 0.98,
and 0.95, respectively. For measurements of the EEM, SA,
NA and AA in the quadrant of the cross section with the
maximal AA, the intraclass correlation coefficients were
0.89, 0.76, 0.73, and 0.92, respectively.
DISCUSSION
Despite using multiple cross-sectional and volumetric ana-
lytic methods, in a prospective randomized study we were
unable to reproduce the findings of previous IVUS studies
that demonstrated an association between the residual
Table 1. Clinical and Procedural Characteristics of the
Entire Cohort
n (%)
Mean age (yrs  SD) 51.7  8.7
Male 24 (71)
Diabetes mellitus 3 (9)
Hypertension 21 (62)
Smoking 10 (29)
Hypercholesterolemia 22 (65)
Clinical presentation at index procedure
Stable angina 2 (6)
Unstable angina 22 (65)
Non–ST-elevation MI 10 (30)
Clinical status at follow-up IVUS
Routine follow-up 31 (91)
Clinical indication 3 (9)
Lesion type at index procedure
De novo 34 (100)
Treated vessel
LAD 19 (56)
LCX 12 (35)
RCA 2 (6)
LMT 1 (3)
Lesion length (mm  SD) 16.6  8.5
Stent length (mm  SD) 22.6  8.8
Number of stents
1 32 (94)
2 2 (6)
Balloon inflation pressure (atm  SD) 15.6  3.3
IVUS  intravascular ultrasound; LAD  left anterior descending; LCX  left
circumflex; MI  myocardial infarction; RCA  right coronary artery.
Figure 3. Relationship between percent atheroma and neointimal areas in
a pooled analysis of all cross sections at follow-up; n  626, r  0.11.
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atheroma burden and subsequent neointimal growth. Our
pooled cross-sectional analyses found that only 1.2% to
1.5% of the variation in percent NA could be attributed to
percent AA. When cross-sectional analyses were performed
for individual patients, we found no consistent association
between these two variables. Finally, we found no relation-
ship between residual atheroma burden and follow-up
neointimal growth using volumetric analysis. These findings
suggest that any apparent relationship between atheroma
burden and neointimal growth is not clinically relevant.
The disparity between our findings and those of previous
IVUS studies is not easily explained. Differences in meth-
odology exist between our study and those of most previous
investigators. We examined the axial and circumferential
relationship between atheroma and neointima in the same
cross section from IVUS pullbacks at follow-up. Although
Prati et al. (11) used a similar methodology to examine the
axial relationship between atheroma and neointima, the
remaining IVUS studies have reported the axial and circum-
ferential relationship between pre- or postintervention ath-
eroma and follow-up neointima (8–11). Requiring the
matching of pre- or postintervention images with follow-up
images necessitates the use of cross sections with clear
landmarks such as calcification or branch vessels to allow
accurate matching of cross sections and cross-sectional
orientation.
The advantage of our method is that all cross sections
with complete planimetry are included in the analysis,
eliminating selection bias. However, it is not clear how this
difference in cross-sectional selection would result in the
reported difference in the relationship between atheroma
and neointima. The major disadvantage of our method is
that inferences about the relationship between pre- and
postintervention atheroma and neointima require the as-
sumption that no significant change in atheroma occurs
between the time of intervention and follow-up. This
assumption is supported, however, by volumetric analyses
showing no significant change in atheroma volume between
the two time points (11). In addition, in a cross-sectional
study by Mudra et al. (3), no significant change in AA was
found in 80% of cross sections between intervention and
six-month follow-up.
The method we used to examine the circumferential
relationship between atheroma and neointima is novel.
Previous studies have used semiquantitative methods to
describe this relationship. The study by Shiran et al. (9) only
studied those cross sections with both an eccentric distribu-
tion of atheroma (maximal/minimal atheroma thickness
2) and significant neointimal growth (neointimal thick-
ness of 0.5 mm). Hibi et al. (8) used a method that
required the measurement of an angle between the site of
maximal atheroma and neointimal thickness. In this study,
it is unclear whether cross sections with a uniform distribu-
tion of atheroma were included. Our method included all
prespecified cross sections and reported the quantitative
relationship between atheroma and neointima in each cross-
sectional quadrant.
Differences in patient-, lesion- or procedure-related char-
acteristics may also explain some of the disparity between
this study and others. Given the small numbers of patients
in this and other studies, it is difficult to correct for such
differences. Previous studies have included patients who
underwent routine follow-up examinations. It is unclear
how accurately these studied patients included in previous
analyses reflect the entire population undergoing coronary
intervention. The current study, however, is also likely to be
subject to patient selection bias, given the 50% follow-up
rate in the IVUS substudy of the AMIGO trial, and the
binary restenosis rate of only 12.5% in the patient cohort.
One of the peculiar differences between this study and
that of Prati et al. (11) is that 11.6% of all cross sections in
this study demonstrated no neointimal growth despite
having a significant atheroma burden (50.2  13.5%). Such
cross sections were completely absent in the study by Prati
et al. (11). The presence of such cross sections supports the
contention that no consistent relationship exists between
atheroma burden and neointima growth.
Despite the disparity between the findings in this study
and other previous IVUS studies, there is supportive evi-
dence for our conclusions. In the largest postmortem study
of in-stent restenosis in humans, Farb et al. (13) demon-
strated that neointimal thickness at stent strut sites was
greatest at sites of medial injury. Neointimal thickness was
not related to atheroma burden if the media was intact.
Grewe et al. (14) have demonstrated in a postmortem model
of stent deployment in coronary vessels with type B2 and C
atherosclerotic lesions that the highest degree of vessel
injury occurs in anatomically nondiseased or only slightly
fibrosed portion of the vessel. Because vessel injury score has
been shown to be highly predictive of neointimal prolifer-
ation in animal models of restenosis (15,16), this suggests
Figure 4. Relationship of percent atheroma volume postintervention and
percent neointimal volume at follow-up in 26 patients with volumetric
data; n  26, r  0.1, p  0.62.
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that neointimal growth is unlikely to occur maximally at the
sites of greatest atheroma burden.
Variation in the cellular or chemical composition of
atheroma may explain differing relationships between ath-
eroma burden and neointima and the overall absence of a
relationship. This hypothesis is supported by a number of
observations. Patients with type B versus type A atheroma
have larger lumen loss because of neointimal growth (3).
Farb et al. (13) have demonstrated that 44% of stent struts
in contact with lipid core (as a result of focal penetration by
stent strut) demonstrate 	3 inflammation (i.e., 20 in-
flammatory cells) compared with 3% of stent struts in
contact with fibrous plaque. A strong association between
an aggressive inflammatory response and an exaggerated
neointimal response is suggested from animal studies (17).
Moreno et al. (18), using atherectomy specimens from
patients with unstable angina, reported that macrophage-
rich areas in the plaque tissue were larger in patients with
in-stent restenosis versus those patients without restenosis.
Study limitations. The relationship between the various
measures of atheroma burden and neointimal growth was a
univariate analysis. In the analysis of the axial relationship
between total plaque area and NA at follow-up, only those
cross sections with planimetry of LA, SA, and EEM could
be included in the analysis. Exclusion of cross sections with
nonmeasurable borders, which is not a random process, may
have altered the relationships that we observed. However,
this limitation is common to all cross-sectional IVUS
studies and cannot be remedied.
Conclusions. A remarkably consistent lack of a clinically
significant relationship between various volumetric and
cross-sectional measures of atheroma burden and neointi-
mal growth was found in patients undergoing stenting
alone in this study. This finding differs from previous
studies and suggests that atheroma burden does not play
an important role in the pathogenesis of neointimal
growth. If atheroma plays a role in neointimal growth,
atheroma composition rather than burden may be the
more critical determinant.
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